Document is current
Any future updates will be listed below
-
Authors
Reich, Christoph
Salbach, Christian
Yildirim, Mustafa
Hilbel, Thomas
Hund, Hauke
Frey, Norbert
Katus, Hugo A.
Giannitsis, Evangelos https://orcid.org/0000-0002-1025-2872
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 13 January 2026
Accepted: 11 April 2026
First Online: 11 May 2026
Declarations
: EG holds a patent on the CDS triage algorithm jointly with Roche Diagnostics. He received honoraria for lectures from Roche Diagnostics, AstraZeneca, Bayer, Daiichi-Sankyo, Lilly Eli Deutschland. He serves as a consultant for Roche Diagnostics, BRAHMS Thermo Fisher Scientific, Boehringer Ingelheim and has received research funding from BRAHMS Thermo Fisher Scientific, Roche Diagnostics, Bayer Vital and Daiichi Sankyo. CR has received honoraria for lectures from Roche Diagnostics and AstraZeneca, travel support from Bayer and AstraZeneca, and research funding from AstraZeneca and Cardisio. NF has received speaker honoraria from Daiichi Sankyo, Astra Zeneca, Boehringer Ingelheim and Bayer Vital. He serves as a consultant for CMS. There are no disclosures for MY, TH, HH and CS.
